Jared Watkin, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,978 shares at $44.99 ($89K) on 2017-02-21, disclosed to the SEC on 2017-02-22.
Scheduled sale ($89k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.69 | 740 | $33K | 37.3% |
| 2 | $44.69 | 683 | $31K | 34.5% |
| 3 | $44.98 | 100 | $4K | 5.1% |
| 4 | $44.98 | 300 | $13K | 15.2% |
| 5 | $44.99 | 55 | $2K | 2.8% |
| 6 | $44.99 | 100 |
| $4K |
| 5.1% |
| Total | $44.77 avg | 1,978 | $89K | 100% |
| Filing → |
| ABT | SELL | 2021-05-04 | $22.7M | — | Filing → |
| ABT | SELL | 2021-03-02 | $336K | — | Filing → |
| ABT | SELL | 2020-03-10 | $676K | — | Filing → |